247 related articles for article (PubMed ID: 16688727)
1. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.
Sinicrope FA
Mol Carcinog; 2006 Jun; 45(6):447-54. PubMed ID: 16688727
[TBL] [Abstract][Full Text] [Related]
2. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
3. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 as a target for anticancer drug development.
Méric JB; Rottey S; Olaussen K; Soria JC; Khayat D; Rixe O; Spano JP
Crit Rev Oncol Hematol; 2006 Jul; 59(1):51-64. PubMed ID: 16531064
[TBL] [Abstract][Full Text] [Related]
5. Role of cyclooxygenase-2 in colorectal cancer.
Sinicrope FA; Gill S
Cancer Metastasis Rev; 2004; 23(1-2):63-75. PubMed ID: 15000150
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
Sanborn R; Blanke CD
Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508
[TBL] [Abstract][Full Text] [Related]
7. Prevention of colorectal cancer through the use of COX-2 selective inhibitors.
Peek RM
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S50-6. PubMed ID: 15309515
[TBL] [Abstract][Full Text] [Related]
8. Role of cyclooxygenase-2 in pathogenesis and prevention of colorectal cancer.
Hahn E; Kraus S; Arber N
Dig Dis; 2010; 28(4-5):585-9. PubMed ID: 21088406
[TBL] [Abstract][Full Text] [Related]
9. COX-2 inhibition and prevention of cancer.
Giercksky KE
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):821-33. PubMed ID: 11566043
[TBL] [Abstract][Full Text] [Related]
10. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
Tuynman JB; Peppelenbosch MP; Richel DJ
Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
[TBL] [Abstract][Full Text] [Related]
11. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase 2: a molecular target for cancer prevention and treatment.
Subbaramaiah K; Dannenberg AJ
Trends Pharmacol Sci; 2003 Feb; 24(2):96-102. PubMed ID: 12559775
[TBL] [Abstract][Full Text] [Related]
13. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
Kaidi A; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.
Lin DT; Subbaramaiah K; Shah JP; Dannenberg AJ; Boyle JO
Head Neck; 2002 Aug; 24(8):792-9. PubMed ID: 12203806
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase as a target in lung cancer.
Brown JR; DuBois RN
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
[TBL] [Abstract][Full Text] [Related]
16. [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
Buecher B; Heymann MF; Blottière HM
Gastroenterol Clin Biol; 2001 Nov; 25(11):967-78. PubMed ID: 11845047
[No Abstract] [Full Text] [Related]
17. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
18. Prospects in NSAID-derived chemoprevention of colorectal cancer.
Chell S; Patsos HA; Qualtrough D; H-Zadeh AM; Hicks DJ; Kaidi A; Witherden IR; Williams AC; Paraskeva C
Biochem Soc Trans; 2005 Aug; 33(Pt 4):667-71. PubMed ID: 16042570
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2: from inflammation to carcinogenesis.
Ristimäki A
Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
[TBL] [Abstract][Full Text] [Related]
20. [COX and study of cancer therapy].
Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1147-51. PubMed ID: 15332534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
